In studies of phosphorylated ER (pER), an activated form of ER present in both primary and metastatic breast cancers, our group identified the nuclear transcription factor Grainyhead-like protein 2 (GRHL2) as a cooperating factor [7,8]. Here, GRHL2 is linked to breast carcinoma.